Description
This modifier indicates that a drug or biological product was acquired through the 340B drug pricing program, which provides significant discounts. It is specifically used by non-excepted off-campus provider-based departments of a hospital that are reimbursed under the provider fee schedule, ensuring proper reporting of discounted drug costs.